Pathogenetic bases of the combined use of drugs from the groups of hepatoprotectors and phytosorbents

Abstract

The combined use of hepatoprotectors and phytosorbents in theory is a promising method of pharmacotherapy of comorbid pathologies, as it creates the possibility of presenting them as the result of an extended search for the most relevant forms of manifestation of metabolic disorders, the results of which made it possible to identify general patterns of development and, accordingly, the main directions for their leveling.It was revealed that the main pathogenetic trend is the failure of metabolic processes in the gastrointestinal tract, which reduces the efficiency of feeding and causes a decrease or fluctuations in productivity (or product quality), the subsequent accumulation of products of disturbed metabolic processes with toxic properties - the development of a local syndrome of endogenous intoxication, a violation of the processes of cavitary and symbiotic digestion in the gastrointestinal tract, with increased alimentary insufficiency, functional overload of the digestive organs and primarily the liver, imbalance of the microbiota and local barrier mechanisms, generalization of the pathological process in the form of the development of systemic endogenous intoxication with the corresponding toxic depression of immunity, functions of organs and body systems, including including dysfunctions and the development of pathology of the hepatobiliary system, in the form of systemic metabolic disorders with the occurrence of a secondary deficiency of nutrients and biologically active substances, acid disorders butalkaline balance and dystrophic phenomena.The main purpose of this article is, based on the analysis of literary sources, to identify the pathogenetic basis for the combined use of drugs from the hepatoprotector groups and phytosorbents.We searched for original studies in the scientific databases PubMed, Elsevier Science (Scopus) and Clarivate Analytics (Web of Science) over the past 20 years to identify the features of the above processes, after which a formalized content analysis of the found publications was carried out.A better understanding of the various mechanisms involved in pathogenesis involving the liver and intestinal microbiota will contribute to the development of improved pharmacological approaches to the treatment of these pathologies.